Mechanisms of granulocyte homeostasis
Mechanisms of granulocyte homeostasis
批准号:
9973861
负责人:
H. LEIGHTON GRIMES
金额:
$59.21万
依托单位国家:
美国
项目类别:
财政年份:
2015
资助国家:
美国
项目状态:
已结题
起止时间:
2015-07-01 至 2024-04-30
关键词:
ATAC-seqAddressBindingBiological AssayCSF3 geneCell modelCell surfaceCellsCessation of lifeChIP-seqChromatinClinicalComplexDataData SetDevelopmentDiseaseEnhancersEpitopesEventExtravasationGFI1 geneGene ExpressionGenerationsGenesGeneticGenetic TranscriptionGenomicsGranulopoiesisHalf-LifeHematopoieticHomeostasisHost DefenseHumanImmuneImmune System DiseasesImmune signalingInnate Immune SystemInvestigationLinkMarrowMediatingModelingMolecularMolecular ProfilingMusMutationMyelogenousMyeloid CellsMyeloproliferative diseaseNatural ImmunityNeonatalNeutropeniaNeutrophiliaNormal CellPathway interactionsPatientsProcessProductionRegulator GenesRoleSamplingTissuesTranscriptional RegulationVariantbioinformatics toolcell typecytokinedifferential expressiongenetic variantgranulocytegut microbiomehuman modelinfection riskinnate immune functioninsightmacrophagemicrobialmicrobial colonizationmicrobiomemonocytemouse modelmutantneutrophilnovelprogenitorprogramspromoterreceptorrepairedsingle-cell RNA sequencingtranscription factortranscriptome
中文摘要
点击翻译按钮获取中文摘要
英文摘要
SUMMARY
Understanding the cellular and molecular processes underlying granulocyte homeostasis is crucial because
producing too few granulocytes results in increased risk for infection (neutropenia), while producing too many
granulocytes can result in severe tissue damage and death (myeloproliferative disorders). To delineate the
molecular mechanisms underlying homeostatic neutrophil production, we previously delineated hierarchical
genomic and regulatory states culminating in neutrophil or macrophage specification. Myeloid cells undergoing
lineage specification traverse successive states of mixed-lineage gene expression dictated by antagonistic
transcriptional programs (HSCP vs. myeloid progenitor, then Irf8 vs. Gfi1) that culminate in generation of
neutrophil or monocyte precursors. Using neutropenia-patient-derived mutations in the GFI1 transcription
factor, we generated mouse models of congenital neutropenia. To delineate the molecular mechanisms
underlying homeostatic neutropenia and innate immune dysfunction in these mice, we first captured normal
cell states encompassing neutrophil specification and commitment, then built a computational approach to
assign neutropenia-model cells to normal cell states and assess cell-state specific variation in gene
expression. Surprisingly, the majority of differentially expressed GFI1-target genes are sequentially altered as
cells traverse successive states. Underscoring these cell state-specific insights, genetic rescue impacts
specification but not innate immunity programmed during commitment. Here, we propose to provide regulatory
insight explaining this finding; defining altered Gfi1-mutant binding and stage-specific open chromatin. Next, we
will determine how neutrophil defense functions are programmed during commitment, and how that fails in
humans and mice with neutropenia. Finally, we will revisit the gene regulatory network underlying homeostatic
neutrophil versus macrophage specification in the context of establishing neutrophil homeostasis through
waves of neonatal gut microbiome colonization. We propose that mouse modeling of mutations identified in
neutropenic patients can be exploited to reveal the essential pathobiology of neutropenia, and to dissect
mechanisms underlying normal innate immune function and the establishment of granulocyte homeostasis.
1
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Modeling myelodysplasia
-
批准号:10157422
-
项目类别:
-
资助金额:$61.42万
-
财政年份:2021
-
负责人:H. LEIGHTON GRIMES
-
依托单位:
Modeling myelodysplasia
-
批准号:10320969
-
项目类别:
-
资助金额:$59.25万
-
财政年份:2021
-
负责人:H. LEIGHTON GRIMES
-
依托单位:
Modeling myelodysplasia
-
批准号:10541117
-
项目类别:
-
资助金额:$57.71万
-
财政年份:2021
-
负责人:H. LEIGHTON GRIMES
-
依托单位:
A generalizable framework for linking single-cell genomic states with cell fate outcomes in hematopoiesis
-
批准号:10410480
-
项目类别:
-
资助金额:$106.15万
-
财政年份:2020
-
负责人:H. LEIGHTON GRIMES
-
依托单位:
A generalizable framework for linking single-cell genomic states with cell fate outcomes in hematopoiesis
-
批准号:10237929
-
项目类别:
-
资助金额:$106.15万
-
财政年份:2020
-
负责人:H. LEIGHTON GRIMES
-
依托单位:
A generalizable framework for linking single-cell genomic states with cell fate outcomes in hematopoiesis
-
批准号:10645197
-
项目类别:
-
资助金额:$106.15万
-
财政年份:2020
-
负责人:H. LEIGHTON GRIMES
-
依托单位:
A rapid spontaneous murine model of CN-AML
-
批准号:9174448
-
项目类别:
-
资助金额:$62.54万
-
财政年份:2016
-
负责人:H. LEIGHTON GRIMES
-
依托单位:
Mechanisms of granulocyte homeostasis
-
批准号:10609865
-
项目类别:
-
资助金额:$57.52万
-
财政年份:2015
-
负责人:H. LEIGHTON GRIMES
-
依托单位:
Mechanisms of granulocyte homeostasis
-
批准号:10396529
-
项目类别:
-
资助金额:$57.6万
-
财政年份:2015
-
负责人:H. LEIGHTON GRIMES
-
依托单位:
Mechanisms of granulocyte homeostasis
-
批准号:9263013
-
项目类别:
-
资助金额:$39.0万
-
财政年份:2015
-
负责人:H. LEIGHTON GRIMES
-
依托单位:
Developing Novel STAT5 Protein Inhibitors for treatment of leukemias
-
批准号:8748068
-
项目类别:
-
资助金额:$16.97万
-
财政年份:2014
-
负责人:H. LEIGHTON GRIMES
-
依托单位:
MicroRNA in Acute Myeloid Leukemia
-
批准号:8658698
-
项目类别:
-
资助金额:$30.8万
-
财政年份:2011
-
负责人:H. LEIGHTON GRIMES
-
依托单位:
MicroRNA in Acute Myeloid Leukemia
-
批准号:8130465
-
项目类别:
-
资助金额:$31.75万
-
财政年份:2011
-
负责人:H. LEIGHTON GRIMES
-
依托单位:
MicroRNA in Acute Myeloid Leukemia
-
批准号:8472461
-
项目类别:
-
资助金额:$29.84万
-
财政年份:2011
-
负责人:H. LEIGHTON GRIMES
-
依托单位:
MicroRNA in Acute Myeloid Leukemia
-
批准号:8852567
-
项目类别:
-
资助金额:$31.75万
-
财政年份:2011
-
负责人:H. LEIGHTON GRIMES
-
依托单位:
Epigenetic manipulation of Leukemia
-
批准号:7761020
-
项目类别:
-
资助金额:$20.96万
-
财政年份:2009
-
负责人:H. LEIGHTON GRIMES
-
依托单位:
Molecular Mechanism of Severe Congenital Neutropenia
-
批准号:7837525
-
项目类别:
-
资助金额:$24.28万
-
财政年份:2009
-
负责人:H. LEIGHTON GRIMES
-
依托单位:
A Molecular Basis for Neuroendocrine Carcinogenesis
-
批准号:6992691
-
项目类别:
-
资助金额:$23.33万
-
财政年份:2005
-
负责人:H. LEIGHTON GRIMES
-
依托单位:
A Molecular Basis for Neuroendocrine Carcinogenesis
-
批准号:6859226
-
项目类别:
-
资助金额:$24.08万
-
财政年份:2005
-
负责人:H. LEIGHTON GRIMES
-
依托单位:
A Molecular Basis for Neuroendocrine Carcinogenesis
-
批准号:7540459
-
项目类别:
-
资助金额:$23.33万
-
财政年份:2005
-
负责人:H. LEIGHTON GRIMES
-
依托单位:
海外基金